[HTML] sciencedirect.com

[HTML][HTML] Low-dose total body irradiation added to fludarabine and busulfan reduced-intensity conditioning reduces graft failure in patients with myelofibrosis

CW Freyer, DV Babushok, NV Frey, SI Gill… - … and Cellular Therapy, 2022 - Elsevier
Allogeneic hematopoietic cell transplantation (alloHCT) is indicated for patients with
intermediate-risk or high-risk myelofibrosis (MF) and remains the sole potential cure …
被引用次数：7 相关文章

Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis.

CW Freyer, DV Babushok, NV Frey, SI Gill… - … and Cellular Therapy, 2022 - europepmc.org
Allogeneic hematopoietic cell transplantation (alloHCT) is indicated for patients with
intermediate-risk or high-risk myelofibrosis (MF) and remains the sole potential cure …

Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis

CW Freyer, DV Babushok, NV Frey… - Transplantation …, 2022 - pubmed.ncbi.nlm.nih.gov
Allogeneic hematopoietic cell transplantation (alloHCT) is indicated for patients with
intermediate-risk or high-risk myelofibrosis (MF) and remains the sole potential cure …
[HTML] astctjournal.org

[HTML][HTML] Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis

CW Freyer, DV Babushok, NV Frey, SI Gill… - … and Cellular Therapy …, 2022 - astctjournal.org
Allogeneic hematopoietic cell transplantation (alloHCT) is indicated for patients with
intermediate-risk or high-risk myelofibrosis (MF) and remains the sole potential cure …